Acute Myeloid Leukemia (AML): Minimal Residual Disease as a Surrogate Enpoint for Clinical Trials
March 4, 2013
*
Please provide your name, affiliation, and contact information.
*
How do you plan to participate in the workshop?
Workshop Location:
FDA White Oak Campus
Building 31
The Great Room (Rm. 1503)
White Oak Conference Center
10903 New Hampshire Avenue
Silver Spring, Maryland
Powered by SurveyMonkey
Check out our sample surveys and create your own now!